Week In Review — April 25

The Week In Review provides an overview of the past week's top healthcare content, including industry news and trends, Mayo Clinic and Mayo Medical Laboratories news and upcoming events.


Researchers See New Importance in Y Chromosome

There is new reason to respect the diminutive male Y chromosome. Besides its long-known role of reversing the default state of being female, the Y chromosome includes genes required for the general operation of the genome, according to two new surveys of its evolutionary history. These genes may represent a fundamental difference in how the cells in men’s and women’s bodies read off the information in their genomes. Via The New York Times.

Read article

FDA outlines plan to regulate e-cigarettes

The Food and Drug Administration will for the first time regulate the booming market of electronic cigarettes, as well as cigars, pipe tobacco and hookahs, under a proposal to be released Thursday. The move would begin to place restrictions on e-cigarettes, a nearly $2 billion industry that for years has operated outside the reach of federal regulators. If adopted, the government’s plan would force manufacturers to curb sales to minors, stop handing out free samples, place health warning labels on their products and disclose the ingredients. Makers of e-cigarettes also would be banned from making health-related claims without scientific evidence. Via Washington Post.

Read article

Appendicitis without surgery may be safe option for some kids

Children with simple cases of appendicitis may be safely treated with antibiotics instead of surgery, suggests a new study. Forgoing surgery to remove the appendix may not be an option for all kids, researchers say, but just three of 30 children who tried the antibiotics-only route ended up needing surgery. "In this group of patients with uncomplicated appendicitis - in the people we studied, non-operative management with antibiotics alone appears to be a reasonable alternative," Dr. Peter Minneci told Reuters Health. Via Reuters.

Read article


2 new drugs aim to prevent migraines; early tests done

Two drugs given to people who suffer migraines reduced the frequency of their headaches in early trials, scientists said…Dr. David Dodick of the Mayo Clinic in Arizona, an author of both studies, said by telephone that rates for placebos are often high in studies of pain, and in this case those rates could be due in part to the high level of anticipation people had for the success of migraine treatment. They also could be affected, as they sometimes are, by the invasiveness of the treatments – injections rather than pills, he said. Via LA Times.

Read article

Those resurrected from heart attacks celebrate life

People who didn’t get an answer when they knocked on death’s door often return with a greater appreciation of life, especially during the resurrection seasons of spring and Easter. A sense of resurrection and rebirth is common among survivors of sudden cardiac arrest, said Dr. Cheri Olson. “My husband and I tease about it — you were dead and you come back to life,” said Olson, a family physician at Mayo Clinic Health System-Franciscan Healthcare who lives in La Crescent.Via La Crosse Tribune.

Read article

Use of Intraoperative Frozen Section Margin Assessment May Decrease Reoperations in Breast Cancer Patients Undergoing Lumpectomy

In female patients undergoing breast cancer lumpectomies, intraoperative frozen section margin assessment has been shown to decrease overall reoperation rates, according to the results of a study reported by Boughey et al in the journal Surgery. This finding may lead to lower health-care costs, a reduction in future surgeries, and improved cancer outcomes. Via ASCO Post.

Read article

New migraine treatments show promise

There are few treatments available for the millions of people who suffer from migraines. New early-stage research offers new hope. Studies presented Tuesday at the American Academy of Neurology's annual meeting suggest that two new drugs may prevent migraines from happening… Goadsby and Dr. David Dodick, co-authors of both studies, say this treatment is exciting because it's entirely new and specific to migraines. Dodick, a professor of neurology at the Mayo Clinic and Chairman of the American Migraine Foundation, said no drugs targeting the treatment of migraines have been developed in the past 50 years. Via CNN.

Read article

DMC public input process begins

Tuesday night the formal public input session of the DMC planning process got started. It was a packed house at the Mayo Civic Center as Rochester residents and those from surrounding communities gathered to meet the newly hired planners and learned about the planning process …"We want to hear from the community -- what excites them about Rochester, what excites them about DMC, how we bring their thoughts, their ideas, the energy, the enthusiasm together to create DMC and bring DMC vision to fruition," said Lisa Clarke who works for the Mayo Clinic, EDA and DMCC Board. Via KTTC.

Read article


This week’s topic: Dr. Richard Seime: Cyberchondria


Call in: 507-282-1234

Twitter: #mayoclinicradio


Andy Tofilon

Andy Tofilon is a Marketing Segment Manager at Mayo Clinic Laboratories.

Leave a Reply

Your email address will not be published. Required fields are marked *